Clinical Significance of HER-2 Splice Variants in Breast Cancer Progression and Drug Resistance

Figure 1

Histological images of breast carcinoma. Images of (a) ductal carcinoma no special type (NST), (b) ductal carcinoma in situ (DCIS), and (c) lobular carcinoma. (d) HercepTest positive staining: immunocytochemical staining indicates HER-2 overexpression in invasive breast cancer (Images courtesy of Dr. D. Hemming, Queen Elizabeth Hospital, Gateshead).

(a)

(b)

(c)

(d)